Repatha Indications/Uses





Zuellig Pharma
Full Prescribing Info
Prevention of Cardiovascular Events: In adults with established cardiovascular disease, Repatha in combination with an optimally dosed statin and/or other lipid-lowering therapies is indicated to reduce the risk of myocardial infarction, stroke, and coronary revascularisation (see Pharmacology: Pharmacodynamics under Actions).
Primary Hyperlipidaemia (Including Heterozygous Familial Hypercholesterolaemia): Repatha is indicated as an adjunct to diet, for the treatment of adults with primary hyperlipidaemia to reduce low density lipoprotein cholesterol (LDL-C): In combination with a statin or statin with other lipid-lowering therapies (e.g. statins, ezetimibe) in patients who are unable to reach LDL-C goals with a statin or; Alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.
Homozygous familial hypercholesterolaemia: Repatha is indicated in adults and adolescents aged 12 years and over with homozygous familial hypercholesterolaemia in combination with other lipid-lowering therapies.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in